Fluidra, S.a. · BME:FDR
Fluidra — Q1 2026 Earnings Presentation
24 slides from Fluidra's earnings presentation, May 6, 2026
Slide 1: Q1 2026 Results
6 MAY 2026 Q1 2026 RESULTS
Slide 2: Disclaimer
DISCLAIMER This document is for information purposes only and does not constitute an offer to sell, exchange or buy, or an invitation to make offers to sell, exchange or buy, securities issued by any of the companies mentioned. This financial information has been prepared in accordance with internat
Slide 3: On the Call Today
ON THE CALL TODAY Eloi Planes Jaime Ramírez Xavier Tintoré Executive Chairman CEO CFO 3 |
Slide 4: Key Messages
KEY MESSAGES • Good Q1 performance, consistent with expectations for the year, with sales up 5%(1) • On a reported basis, negative FX translation effect • Positive volume and price contribution – excellent customer service and continued market share gains • Solid gross margin, driven by the executio
Slide 5: Good Q1 Performance, Consistent with FY Expectations
GOOD Q1 PERFORMANCE, CONSISTENT WITH FY EXPECTATIONS Sales (€M) Adj. EBITDA (€M) and margin (%) 564 564 +5.4%(1) 131 +1.8%(1) 124 (1) (1) 122 535 • 5% sales growth at constant FX 23.2% 22.0% 23.2% 23.2% 22.0% 22.0% • EBITDA margin impacted by geographic and product mix, inflation 2025 2026 2025 2026
Slide 6: Strong Performance Across Regions
STRONG PERFORMANCE ACROSS REGIONS YoY % growth % of Group’s Sales at const. FX & sales perimeter 564 (28) 17 564 Q1 2026 Q1 2026 2,102 Southern Europe 6% 28% 11 Rest of Europe 4% 12% 1 North America 5% 44% Rest of the World 5% 16% (5%) 0% 2% 3% 0% Q1 ’25 FX Perimeter Price Volume Q1 ’26 Total 5% 100
Slide 7: Executing Our Strategy
EXECUTING OUR STRATEGY Accelerate Foster Enhance growth competitive operational differentiation excellence • VarioPool completion (1% FY • Launched PoolTrackr SaaS • Actions taken to navigate higher sales contribution to Group) in the US to enhance inflation customer experience • Aiper growing stron
Slide 8: Growing Sales and Adjusted EBITDA at Constant FX
GROWING SALES AND ADJUSTED EBITDA AT CONSTANT FX 2025 Evol. • Sales up 5% YoY, with growth across all regions % % % Evol. YTD results €M 2025 Const 2026 Const Sales Sales Sales 26/25 FX FX • Gross margin stable YoY, with inflation and Sales 564 100% 535 100% 564 100% 0.1% 5.4% negative product mix b
Slide 9: Good Progress in Deleveraging
GOOD PROGRESS IN DELEVERAGING Cash flow (abridged) and net debt YTD €M 2025 2026 Evol. 26/25 Adjusted EBITDA 131 124 (6) • Leverage ratio improved 0.1x vs prior Net interest paid (15) (16) (1) year Corporate income tax paid (4) (4) 0 Operating working capital (287) (234) 52 • CF from operating activ
Slide 10: Summary
SUMMARY • Q1 performance consistent with expectations with good sales growth across all regions and robust gross margin • Maintaining guidance: executing on what we can control to deliver full year despite geopolitical and macro-uncertainty, which we continue to monitor: Guidance for FY 2026 (at con
Slide 11: Appendix
APPENDIX = —————— —_ —— Bee SIO RA
Slide 12: Why Fluidra Wins
WHY FLUIDRA WINS Global leader in a structurally attractive industry, with long-term growth underpinned by resilient aftermarket 1 #1 player with unique footprint and broadest product offering. Focus on operational excellence 2 Leaders in customer-centric innovation, connectivity and sustainable poo
Slide 13: Ready for Our Next Phase of Development
READY FOR OUR NEXT PHASE OF DEVELOPMENT 2007-2017 2018-2025 Future POST IPO – PRE-MERGER POST MERGER – TODAY NEXT PHASE OF GROWTH • Mostly European focused, with • #1 player worldwide, with • Reinforcing leadership and marginal presence in the US and diversified presence growing in high potential mo
Slide 14: Medium-Term Financial Objectives
MEDIUM-TERM FINANCIAL OBJECTIVES +4% New Build growth Medium-term targets Market Installed base growth to growth +6% +8% Annual Avg. Ticket on Equipment +6% sales growth to >25% Adjusted Weather +/-1% EBITDA margin Market share gains +2% Additional Fluidra growth ROCE >17% Inorganic growth 14 |
Slide 15: Consistent Capital Allocation to Generate Value – Unchanged Framework
CONSISTENT CAPITAL ALLOCATION TO GENERATE VALUE – UNCHANGED FRAMEWORK Accumulated cash deployment since 2019 (c.€1.8bn) 1 • Invest for growth and innovation Organic growth • Capex inc. R&D (c.3% of net sales) 25% 2 • Acquisitions (>1% of sales CAGR) Group RoCE Value-accretive • Investment criteria f
Slide 16: New Pools Currently at Historical Low Levels
NEW POOLS CURRENTLY AT HISTORICAL LOW LEVELS Top 5 countries: Residential new pools: Correction from the Around 55% top 5 countries overbuilding in the of global installed base (thousand units) prior decade >70% 321 Fluidra’s sales 249 203 1980-2025 avg: 214k units 169 2015-2025 avg: 208k units 143
Slide 17: Sales by Geography
SALES BY GEOGRAPHY Evol. Constant Const. FX & YTD €M 2025 % Sales 2026 % Sales Const. FX 26/25 perimeter Perimeter Southern Europe 152 27% 161 28% 6.0% 6.0% 6.0% 6.0% Rest of Europe 65 11% 67 12% 3.5% 3.8% 3.5% 3.8% North America 262 46% 249 44% (5.1%) 5.3% (5.1%) 5.3% Rest of the World 85 15% 88 16
Slide 18: Sales by Business Unit
SALES BY BUSINESS UNIT Evol. Const. FX & YTD €M 2025 % Sales 2026 % Sales 26/25 Perimeter Pool & Wellness 555 98% 556 98% 0.2% 5.4% Residential 405 72% 393 70% (3.0%) 2.9% Commercial 47 8% 47 8% 1.5% 6.3% Residential Pool Water 77 14% 87 15% 13.3% 15.4% Treatment Fluid Handling 26 5% 28 5% 7.8% 12.2
Slide 19: Reconciliation of PBT to Adjusted EBITDA
RECONCILIATION OF PBT TO ADJUSTED EBITDA YTD €M 2025 2026 Evol. 26/25 Profit/loss before tax 65 62 (4.5%) Financial result 18 17 (7.4%) D&A 41 39 (4.7%) Restructuring, M&A and integration expenses 5 5 (8.6%) Stock based compensation expense 2 2 18.3% Adjusted EBITDA 131 124 (4.8%) 19 |
Slide 20: Reconciliation of Profit Attributable to the Parent to Adjusted EPS
RECONCILIATION OF PROFIT ATTRIBUTABLE TO THE PARENT TO ADJUSTED EPS YTD €M 2025 2026 Evol. 26/25 Profit/loss attributable to the parent 48 46 (4.6%) Restructuring, M&A and integration expenses 5 5 (8.6%) Stock based compensation expense 2 2 18.3% Financial result 18 17 (7.4%) Net interest paid (15)
Slide 21: Net Working Capital
NET WORKING CAPITAL % LTM % LTM MARCH €M 2025 2026 Evol. 26/25 sales sales Inventories 519 24.3% 520 23.8% 0.1% Trade and other receivables 530 24.8% 512 23.4% (3.4%) Trade payables 417 19.5% 448 20.5% 7.6% Operating net working capital 632 29.6% 583 26.7% (7.8%) Dividends, earn-outs & others 5 0.2%
Slide 22: Interim Financial Position (Abridged)
INTERIM FINANCIAL POSITION (ABRIDGED) Assets 03/2025 03/2026 Liabilities 03/2025 03/2026 PPE & rights of use 364 385 Share capital 192 192 Goodwill 1,323 1,295 Share premium 1,149 1,149 Other intangible assets 827 741 Retained earnings and other reserves 317 380 Non-current financial assets 19 10 In
Slide 23: Alternative Performance Measures
ALTERNATIVE PERFORMANCE MEASURES Fluidra’s financial statements are prepared according to IFRS and other applicable regulation. The financial information presented in this document also includes Alternative Performance Measures (‘APMs’) prepared according to the group’s reporting model. Please note
Slide 24: Thank You
THANK YOU +34 93 724 39 00 Investor_relations@fluidra.com Avda. Alcalde Barnils 69 - 08174 Sant Cugat (Barcelona) www.fluidra.com